HOLX
Status-Quo-PlayerHologic
$76.01
-0.02%
as of 7 Apr
Power Core
Hologic's moat is the clinical guideline itself, which creates switching costs denominated in procedural disruption rather than dollars.
Direction of Movement
Holding Position in a Structurally Stable Franchise
ROC 200
+16.1%
HOLX
Hologic
$76.01
-0.02%
as of 7 Apr
DCF Fair Value: $109.18
mOS zones are proprietary L17X overlays and do not constitute trading signals or investment advice.
Company Profile
Hologic Inc. is a medical technology company specializing in women's health through early detection and treatment via diagnostics products, medical imaging systems, and surgical solutions. It operates across four key segments: Diagnostics, which includes molecular assays like Aptima for detecting infectious diseases, viral loads, vaginitis, and SARS-CoV-2; Breast Health, offering solutions in radiology, surgery, pathology, and treatment for breast cancer care; GYN Surgical, providing hysteroscopic endometrial ablation, tissue removal, fluid management, and laparoscopic tools; and Skeletal Health. These proprietary products address healthcare needs in screening, diagnosis, and intervention worldwide, with the United States as the primary market, followed by Europe, Asia, and other regions. Hologic Inc. supports healthcare providers in improving patient outcomes in women's health domains. Founded in 1985 and headquartered in Marlborough, Massachusetts, it plays a vital role in the medical diagnostics and imaging sectors.